Oncolytics Biotech (ONCY) Other Non-Current Assets (2022)

Oncolytics Biotech's (ONCY) quarterly Other Non-Current Assets came in at $735229.5 in Q4 2022.

Oncolytics Biotech (ONCY) Other Non-Current Assets (2022) Analysis & Trends

Oncolytics Biotech (ONCY) has 1 years of Other Non-Current Assets data on file, last reported at $735229.5 in Q4 2022.

On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $735229.5 in Q4 2022; TTM through Dec 2022 was $735229.5, a N/A change from a year earlier, with the FY2022 full-year figure at $767627.8, changed N/A from the prior year.
Other Non-Current Assets for Q4 2022 stood at $735229.5.
Over the last five years, Other Non-Current Assets for ONCY reached as high as $735229.5 in Q4 2022 and fell as low as $735229.5 in Q4 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	1.02 Mn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	104.24 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	1.26 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	2.13 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	289.41 Mn
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	124.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	14.48 Mn
10	Oncolytics Biotech	372.40 Mn	372.40 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2022	735,229.53